Back to Results
First PageMeta Content
Medicine / Peptide hormones / Recombinant proteins / Diabetes / Anti-diabetic drugs / Insulin pen / Insulin aspart / Insulin / Novo Nordisk / Eli Lilly and Company / Endocrine system / Biology


FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients Safety Announcement[removed]In an effort to reduce the serious risk of infection spread through sharing of multi-dose
Add to Reading List

Open Document

File Size: 57,59 KB

Share Result on Facebook

City

Buffalo / /

Event

Person Communication and Meetings / /

Facility

Dean Clinic / Army facility / Institute of Safe Medication Practices / /

IndustryTerm

needle stick devices / pen devices / insulin products / multi-dose pen devices / /

MedicalCondition

hepatitis viruses / HIV / side effects involving diabetes / heart disease / serious infections / diabetes / actual infection / Numberous diabetes / adverse events involving diabetes / infection / injectable diabetes / bloodborne disease / infections / multi-dose diabetes / serious infection / blindness / /

MedicalTreatment

medication errors / /

Organization

office of Inspector General / Veterans Health Administration / United States Army / U.S. Food and Drug Administration / Wisconsin office of Rural Health / office of Healthcare Inspections / FDA / Department of Veterans Affairs / Institute of Safe Medication Practices / Centers for Disease Control and Prevention / Medicare / /

Position

Counsel / /

Product

Novolog / Safe Medication / Humulin N / Byetta / Novolog Mix / Humalog Mix / regular insulin / Humalog / glucagon / Novolin N / Acute Care ISMP Medication / Humulin / Lantus / Symlin / Levemir / Diabetes Report medication / Apidra / Humulin R / /

ProvinceOrState

Wisconsin / New York / /

Region

Western New York / /

URL

http /

SocialTag